THE BIOTECH GROWTH TRUST PLC - Holding(s) in Company

PR Newswire

London, October 5

For filings with the FCA include the annex
For filings with issuer exclude the annex

   

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

   

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii The Biotech Growth Trust PLC

   

2 Reason for the notification (please tick the appropriate box or boxes):

   

An acquisition or disposal of voting rights Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments No
An event changing the breakdown of voting rights No
Other (please specify): No

   

3. Full name of person(s) subject to the notification obligation: iii Schroders plc
4. Full name of shareholder(s)  (if different from 3.):iv      
5. Date of the transaction and date on which the threshold is crossed or reached: v 1 October 2015
6. Date on which issuer notified: 5 October 2015
7. Threshold(s) that is/are crossed or reached: vi, vii Above 5%

8. Notified details:
A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after
the triggering
transaction

Number
of
Shares		 Number
of
Voting
Rights
Number
of
shares		 Number
of
voting
rights		 % of voting
rights x
Direct Direct xi Indirect xii Direct Indirect
     Ordinary
GB0000385517		 Below 5% Below 5% 3,122,030 N/A 3,122,030 N/A 5.022%

   

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction

   

Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
                             

   

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction

   

Type of financial
instrument		 Exercise
price		 Expiration
date xvii		 Exercise/
Conversion
period xviii		 Number of voting
rights instrument
refers to		 % of voting
rights xix, xx
Nominal Delta
                       

   

Total (A+B+C)

   

Number of voting rights Percentage of voting rights
     3,122,030 5.022%

   

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Schroder & Co. Limited – 3,122,030 – 5.022%

   

Proxy Voting:
10. Name of the proxy holder: n/a
11. Number of voting rights proxy holder will cease to hold: n/a
12. Date on which proxy holder will cease to hold voting rights: n/a

   

13. Additional information: The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issued share capital amount 62,160,892
14. Contact name: Chloe Talbot
15. Contact telephone number: 020 7658 6000